Back
Protagonist Therapeutics Stock Predictions
Sponsored
PTGX
Sponsored
Urgent: The Biggest Gold Bull Market in History Is Here
Click here for urgent details - don't miss out.
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
47.65
Seasonality Move:
13.55%
7 Day Trial
ALL ACCESS PASS
$
7
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.Protagonist Therapeutics Stock Forecast
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 30.3% based on the past 8 years of stock performance.
- Protagonist Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Protagonist Therapeutics Stock Undervalued?
The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. - PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 30.3% based on the past 8 years of stock performance.
Protagonist Therapeutics Stock Rating
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics overpriced?
- Protagonist Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
48.32
52-Week Low:
13.72
Prediction Charts
Market Cap:
2.81B
Price in USD:
47.64
Volume:
598.54K
Beta:
2.10
Technical Analysis
SMA50:
43.19
SMA100:
38.75
SMA200:
33.03
52-Wk Change:
208.55%
Stock Predictions
-
Is Protagonist Therapeutics stock public?
Yes, Protagonist Therapeutics is a publicly traded company. -
What is the Protagonist Therapeutics stock quote today?
The Protagonist Therapeutics stock price is 47.64 USD today. -
How to buy Protagonist Therapeutics stock online?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-26 | 46.25 | 44.93 | 46.78 | 44.64 |
Sep-27 | 45.24 | 44.56 | 45.27 | 44.30 |
Sep-30 | 44.02 | 44.98 | 45.38 | 44.01 |
Oct-1 | 44.81 | 44.32 | 45.33 | 43.41 |
Oct-2 | 44.15 | 44.98 | 45.06 | 43.56 |
Oct-3 | 44.91 | 44.34 | 45.24 | 43.93 |
Oct-4 | 44.63 | 44.37 | 45.24 | 44.16 |
Oct-7 | 44.18 | 43.75 | 44.24 | 42.78 |
Oct-8 | 44.15 | 43.96 | 44.67 | 43.92 |
Oct-9 | 43.95 | 44.18 | 44.61 | 43.33 |
Oct-10 | 43.64 | 43.59 | 44.53 | 43.18 |
Oct-11 | 43.56 | 45.08 | 45.34 | 43.56 |
Oct-14 | 44.96 | 46.35 | 46.90 | 44.77 |
Oct-15 | 46.62 | 47.64 | 48.32 | 46.59 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.